(Press-News.org) TUCSON, Ariz., July 6, 2023 — Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Rochester today announced the release of two seminal publications about digital health technologies for Parkinson’s. These technologies, such as smartphones and wearable sensors, offer an opportunity for objective, frequent and remote assessment of people with Parkinson’s.
With 10 million people living with Parkinson’s worldwide, collaboration and data sharing are crucial for driving innovation in drug development for the fastest-growing degenerative neurological condition.
Research leaders at CHeT have joined forces with organizations and regulators through C-Path’s Critical Path for Parkinson’s (CPP) Consortium, a precompetitive public-private partnership. CPP aims to accelerate the regulatory endorsement of digital tools in Parkinson’s clinical trials through its Digital Drug Development Tools (3DT) initiative.
In June 2023, the Journal of Parkinson’s Disease published two open access manuscripts, representing companion papers from this partnership that detail steps in conducting interviews of people with Parkinson’s who participated in a clinical research study using smartphones. The manuscripts report on relevant symptoms in early Parkinson’s and assess the relevance of digital measures from a smartphone application and smartwatch from the patient perspective.
The study was led by Jamie Adams, M.D., Associate Professor of Neurology and Associate Director of CheT at the University of Rochester and Jennifer Mammen, Ph.D., Assistant Professor at the University of Rhode Island, with support from CPP.
“This project pioneers a new path to efficiently advance tools aligned with the patient voice by engaging with regulatory agencies early and often,” said Diane Stephenson, Ph.D., CPP Executive Director. “C-Path remains committed to learning what matters most to people living with Parkinson’s.”
Access the full manuscripts here:
https://pubmed.ncbi.nlm.nih.gov/37212071
https://pubmed.ncbi.nlm.nih.gov/37212073
“These manuscripts describe a novel methodology that will help inform the use of digital health technologies in clinical trials for Parkinson’s disease and support more objective and patient-centered measures. The goal is to enable efficient, data-driven, and patient-centric utilization of digital health technologies to speed therapeutic development,” said Adams. “Sharing the results with the study participants and witnessing how this information helped them in new ways has been most rewarding.”
John Crawford, a CPP advisor, Parkinson’s advocate, and manuscript coauthor states, “Digital health technologies have the potential to significantly impact Parkinson’s management and have already revolutionized clinical trial conduct. Their advancement expedites trials, enhances intelligence, reduces costs, and ultimately accelerates the delivery of new therapies and technologies to patients.”
The new publications coincide with CPP’s participation in the World Parkinson’s Congress taking place in Barcelona, Spain July 4-7, 2023. CPP will present two posters, Recommendations for Parkinson’s Clinical Trials using Digital Health Technologies and Worldwide Collaborative Framework for Optimizing New Parkinson’s Treatment Trials with Patient Centric Outcome Measures, at the conference coauthored by people living with Parkinson’s highlighting the importance of worldwide collaborations.
Critical Path Institute (C-Path) is an independent, nonprofit organization established in 2005 as a public and private partnership. C-Path’s mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. An international leader in forming collaborations, C-Path has established numerous global consortia that currently include more than 1,600 scientists from government and regulatory agencies, academia, patient organizations, disease foundations, and hundreds of pharmaceutical and biotech companies. C-Path U.S. is headquartered in Tucson, Arizona and C-Path in Europe is headquartered in Amsterdam, Netherlands with additional staff in multiple other locations. For more information, visit c-path.org.
Critical Path Institute is supported by the Food and Drug Administration (FDA) of the Department of Health and Human Services (HHS) and is 55% funded by the FDA/HHS, totaling $17,612,250, and 45% funded by non-government source(s), totaling $14,203,111. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. Government.
The Center for Health + Technology (CHeT) is an academic research organization within the University of Rochester Medical Center. We are comprised of six units, with expertise in clinical trials coordination, clinical materials services, patient and caregiver-reported outcome measures, tech research and innovation, data modeling and predictive analysis, and health policy. Our skilled team of consultants are readily available to provide guidance to academic institutions, pharmaceutical companies, technology firms, not-for-profit foundations, advocacy groups, and the federal government.
END
Multistakeholder collaborations are vital to advancing technologies in Parkinson’s
2023-07-06
ELSE PRESS RELEASES FROM THIS DATE:
THC use during pregnancy linked to changes in fetal development
2023-07-06
Oregon Health & Science University researchers showed that consuming THC while pregnant could potentially affect development of the fetus and lead to life-long health impacts for offspring.
The preclinical study was published today in the journal Clinical Epigenetics.
Delta-9-tetrahydrocannabinol, or THC, is the main psychoactive ingredient in cannabis, a substance growing in popularity and availability in the United States. The prevalence of cannabis use in pregnancy is also rapidly increasing, especially during the first trimester — a time when the fetus is most vulnerable to environmental exposures — ...
New insight into how plant cells divide
2023-07-06
Every time a stem cell divides, one daughter cell remains a stem cell while the other takes off on its own developmental journey. But both daughter cells require specific and different cellular materials to fulfill their destinies. Animal stem cells use the cytoskeleton – a transient network of structural tubules – to physically pull the correct materials from the parent cell into each daughter cell during the split. Plants also have stem cells that need to distribute different materials ...
Eliminating extra chromosomes in cancer cells prevent tumor growth
2023-07-06
New Haven, Conn. — Cancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the cells from forming tumors. The findings, said the researchers, suggest that selectively targeting extra chromosomes may offer a new route for treating cancer.
The study was published July 6 in the journal Science.
Human cells typically have 23 pairs of chromosomes; extra chromosomes are an anomaly known as aneuploidy.
“If you look at normal skin or normal lung tissue, for example, 99.9% of the cells will have the right number of chromosomes,” said ...
Fantasy football in math class?
2023-07-06
While mathematics is a fundamental skill crucial to daily life, U.S. parents today see math education as boring, outdated, and disconnected from the real world. (1) At the national level, short and long-term achievement trends paint a disconcerting picture of the need for innovative math education strategies:
Math scores among eighth graders dropped in 2022, to the lowest score since 20031
Math scores declined for students regardless of racial and ethnic group, gender, parental education, or disability status1
The COVID-19 pandemic exacerbated declines in math achievement; the median school district lost about ...
Mobile phone data used for public health underrepresent vulnerable populations
2023-07-06
UNIVERSITY PARK, Pa. — Mobile phone data are increasingly used in public health management and disease outbreak response, as demonstrated during the COVID-19 pandemic when location data were used as a proxy for human movement and contacts and informed exposure notification apps. However, a new study led by researchers at Penn State revealed that phone data may not accurately reflect under-resourced or particularly vulnerable populations, who are often underrepresented in other data as well.
If this bias is not acknowledged or complemented with additional ...
Researchers discover potential molecular indicators for Parkinson’s symptoms
2023-07-06
Hand tremors and slowed movements are two of the most widely recognized hallmarks of Parkinson’s disease, and for many sufferers the first indication that something is amiss. But by the time these symptoms manifest, those patients have already lost 50–80 percent of their dopamine neurons—a mass die-off that causes the neurodegenerative disease. Malfunctions in dopamine-dependent areas of the brain are responsible for many of the symptoms, which differ from person to person in an unpredictable way.
A diagnosis at an early age, typically before age 50, can stave off the most severe symptoms for years; when the disease is identified later, its trajectory is often swift ...
Study supports “catch up” HPV test in older women
2023-07-06
For women over the age of 65 who have never had a high-risk human papillomavirus (HPV) test, a “catch up” HPV screening intervention may improve cervical cancer prevention by detecting more cervical pre-cancer lesions as compared to women not offered screening. That is the conclusion of a new study publishing July 6th in the open access journal PLOS Medicine by Mette Tranberg, University Research Clinic for Cancer Screening, Randers Regional Hospital, Denmark, and colleagues.
High-risk human papillomavirus (HPV) test is replacing cytology as the primary cervical cancer screening test in most countries, but many women over 65 years have never had an HPV ...
The solstice switch: Warming’s effects on autumn leaf senescence depend on timing
2023-07-06
How temperate and boreal trees’ leaves respond to climate change remains uncertain. Now, a new study of northern forests reports that while early-season climate warming – that occurring before the summer solstice – tends to be associated with earlier autumn leaf senescence, late-season warming (after the summer solstice) has the opposite impact, delaying onset of leaf senescence in fall. “Improved models of plant development and growth under climate change will need to incorporate the reversal of warming effects after the summer solstice,” write Constantin Zohner and colleagues, authors of the study. Climate change ...
Two studies report: Perovskite-silicon tandem cells that break the 30% efficiency threshold
2023-07-06
In two separate studies, researchers present novel methods that enable the fabrication of high-performance perovskite-silicon tandem solar cells with power conversion efficiencies exceeding 30%. Silicon solar cells – the most commonly deployed photovoltaic (PV) technology – are rapidly approaching their theoretical power conversion efficiency (PCE) limit of 29%. One way to increase the efficiency of a solar cell is to optimize the spectrum of sunlight for conversion into energy. This can be done by stacking two or more interconnected photoactive materials into a singular device, improving ...
Precipitation tolerance helped explain which vertebrate species spread between newly joined continents
2023-07-06
A new study helps explain why rates of species exchange are at least twice as high from west to east than in the opposite direction across Wallace’s Line. The study included an analysis of more than 20,000 species belonging to all 227 families of terrestrial vertebrates present in the Indo-Australian archipelago. As tectonic plates merge, once disparate continents can connect and create new opportunities for biotic exchange. Species movement across newly connected continents millions of years ago continues to shape assemblages of flora and fauna today. One of the most well-known ...